Aura Biosciences

This study is testing a new drug called belzupacap sarotalocan for people with early-stage eye tumors. It aims to see if the drug, which is injected near the eye and activated with a laser, is safe and can stop the tumors from growing better than a sham (fake) procedure. The tria…

This study is testing a new drug called belzupacap sarotalocan for people whose cancer has spread from another part of the body to the eye. The main goal is to see if the treatment is safe and tolerable when injected near the eye. Researchers will also check if the treatment help…

This early-stage trial is testing a new drug called belzupacap sarotalocan (AU-011) for bladder cancer that hasn't spread into the muscle wall. Researchers will inject the drug directly into tumors during a standard bladder procedure to see if it's safe and practical to use. The …

This study aims to understand how a specific eye cancer treatment affects patients' quality of life, symptoms, and daily functioning. It involves 15 people who are already enrolled in a related treatment trial. Researchers will collect feedback through online surveys over two yea…